| R-HSA-109581 | Apoptosis | IEA |
| R-HSA-110312 | Translesion synthesis by REV1 | TAS |
| R-HSA-110313 | Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | TAS |
| R-HSA-110314 | Recognition of DNA damage by PCNA-containing replication complex | TAS |
| R-HSA-110320 | Translesion Synthesis by POLH | TAS |
| R-HSA-1168372 | Downstream signaling events of B Cell Receptor (BCR) | TAS |
| R-HSA-1169091 | Activation of NF-kappaB in B cells | TAS |
| R-HSA-1169408 | ISG15 antiviral mechanism | TAS |
| R-HSA-1169410 | Antiviral mechanism by IFN-stimulated genes | TAS |
| R-HSA-1227986 | Signaling by ERBB2 | TAS |
| R-HSA-1234174 | Regulation of Hypoxia-inducible Factor (HIF) by oxygen | TAS |
| R-HSA-1234176 | Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | TAS |
| R-HSA-1236382 | Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | TAS |
| R-HSA-1236394 | Signaling by ERBB4 | TAS |
| R-HSA-1236974 | ER-Phagosome pathway | IEA |
| R-HSA-1236975 | Antigen processing-Cross presentation | IEA |
| R-HSA-1253288 | Downregulation of ERBB4 signaling | TAS |
| R-HSA-1257604 | PIP3 activates AKT signaling | TAS |
| R-HSA-1266738 | Developmental Biology | TAS |
| R-HSA-1266738 | Developmental Biology | IEA |
| R-HSA-1280215 | Cytokine Signaling in Immune system | TAS |
| R-HSA-1280218 | Adaptive Immune System | TAS |
| R-HSA-1280218 | Adaptive Immune System | IEA |
| R-HSA-1295596 | Spry regulation of FGF signaling | TAS |
| R-HSA-1358803 | Downregulation of ERBB2:ERBB3 signaling | TAS |
| R-HSA-1430728 | Metabolism | TAS |
| R-HSA-1430728 | Metabolism | IEA |
| R-HSA-156827 | L13a-mediated translational silencing of Ceruloplasmin expression | TAS |
| R-HSA-156842 | Eukaryotic Translation Elongation | IEA |
| R-HSA-156902 | Peptide chain elongation | IEA |
| R-HSA-157118 | Signaling by NOTCH | IEA |
| R-HSA-157118 | Signaling by NOTCH | TAS |
| R-HSA-162582 | Signal Transduction | TAS |
| R-HSA-162582 | Signal Transduction | IEA |
| R-HSA-162587 | HIV Life Cycle | TAS |
| R-HSA-162588 | Budding and maturation of HIV virion | TAS |
| R-HSA-162599 | Late Phase of HIV Life Cycle | TAS |
| R-HSA-162906 | HIV Infection | TAS |
| R-HSA-162909 | Host Interactions of HIV factors | TAS |
| R-HSA-1640170 | Cell Cycle | TAS |
| R-HSA-1643685 | Disease | TAS |
| R-HSA-1643713 | Signaling by EGFR in Cancer | TAS |
| R-HSA-166016 | Toll Like Receptor 4 (TLR4) Cascade | TAS |
| R-HSA-166058 | MyD88:Mal cascade initiated on plasma membrane | TAS |
| R-HSA-166166 | MyD88-independent TLR4 cascade | TAS |
| R-HSA-168138 | Toll Like Receptor 9 (TLR9) Cascade | TAS |
| R-HSA-168142 | Toll Like Receptor 10 (TLR10) Cascade | TAS |
| R-HSA-168164 | Toll Like Receptor 3 (TLR3) Cascade | TAS |
| R-HSA-168176 | Toll Like Receptor 5 (TLR5) Cascade | TAS |
| R-HSA-168179 | Toll Like Receptor TLR1:TLR2 Cascade | TAS |
| R-HSA-168181 | Toll Like Receptor 7/8 (TLR7/8) Cascade | TAS |
| R-HSA-168188 | Toll Like Receptor TLR6:TLR2 Cascade | TAS |
| R-HSA-168249 | Innate Immune System | TAS |
| R-HSA-168254 | Influenza Infection | TAS |
| R-HSA-168255 | Influenza Life Cycle | TAS |
| R-HSA-168256 | Immune System | TAS |
| R-HSA-168256 | Immune System | IEA |
| R-HSA-168273 | Influenza Viral RNA Transcription and Replication | TAS |
| R-HSA-168638 | NOD1/2 Signaling Pathway | TAS |
| R-HSA-168643 | Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | TAS |
| R-HSA-168898 | Toll-Like Receptors Cascades | TAS |
| R-HSA-168927 | TICAM1, RIP1-mediated IKK complex recruitment | TAS |
| R-HSA-168928 | DDX58/IFIH1-mediated induction of interferon-alpha/beta | TAS |
| R-HSA-169911 | Regulation of Apoptosis | IEA |
| R-HSA-170834 | Signaling by TGF-beta Receptor Complex | TAS |
| R-HSA-170834 | Signaling by TGF-beta Receptor Complex | IEA |
| R-HSA-174048 | APC/C:Cdc20 mediated degradation of Cyclin B | TAS |
| R-HSA-174084 | Autodegradation of Cdh1 by Cdh1:APC/C | TAS |
| R-HSA-174113 | SCF-beta-TrCP mediated degradation of Emi1 | TAS |
| R-HSA-174143 | APC/C-mediated degradation of cell cycle proteins | TAS |
| R-HSA-174154 | APC/C:Cdc20 mediated degradation of Securin | TAS |
| R-HSA-174178 | APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | TAS |
| R-HSA-174184 | Cdc20:Phospho-APC/C mediated degradation of Cyclin A | TAS |
| R-HSA-174490 | Membrane binding and targetting of GAG proteins | TAS |
| R-HSA-174495 | Synthesis And Processing Of GAG, GAGPOL Polyproteins | TAS |
| R-HSA-175474 | Assembly Of The HIV Virion | TAS |
| R-HSA-176408 | Regulation of APC/C activators between G1/S and early anaphase | TAS |
| R-HSA-176409 | APC/C:Cdc20 mediated degradation of mitotic proteins | TAS |
| R-HSA-176814 | Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | TAS |
| R-HSA-177929 | Signaling by EGFR | TAS |
| R-HSA-179409 | APC-Cdc20 mediated degradation of Nek2A | TAS |
| R-HSA-179419 | APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | TAS |
| R-HSA-1799339 | SRP-dependent cotranslational protein targeting to membrane | IEA |
| R-HSA-1799339 | SRP-dependent cotranslational protein targeting to membrane | TAS |
| R-HSA-180534 | Vpu mediated degradation of CD4 | TAS |
| R-HSA-180585 | Vif-mediated degradation of APOBEC3G | TAS |
| R-HSA-181438 | Toll Like Receptor 2 (TLR2) Cascade | TAS |
| R-HSA-182971 | EGFR downregulation | TAS |
| R-HSA-1834949 | Cytosolic sensors of pathogen-associated DNA | TAS |
| R-HSA-187577 | SCF(Skp2)-mediated degradation of p27/p21 | TAS |
| R-HSA-190236 | Signaling by FGFR | TAS |
| R-HSA-192823 | Viral mRNA Translation | TAS |
| R-HSA-193639 | p75NTR signals via NF-kB | TAS |
| R-HSA-193704 | p75 NTR receptor-mediated signalling | TAS |
| R-HSA-195253 | Degradation of beta-catenin by the destruction complex | TAS |
| R-HSA-195721 | Signaling by WNT | TAS |
| R-HSA-1980143 | Signaling by NOTCH1 | IEA |
| R-HSA-1980143 | Signaling by NOTCH1 | TAS |
| R-HSA-1980145 | Signaling by NOTCH2 | IEA |
| R-HSA-199991 | Membrane Trafficking | TAS |
| R-HSA-201681 | TCF dependent signaling in response to WNT | TAS |
| R-HSA-202403 | TCR signaling | TAS |
| R-HSA-202424 | Downstream TCR signaling | TAS |
| R-HSA-204998 | Cell death signalling via NRAGE, NRIF and NADE | TAS |
| R-HSA-205043 | NRIF signals cell death from the nucleus | TAS |
| R-HSA-209543 | p75NTR recruits signalling complexes | TAS |
| R-HSA-209560 | NF-kB is activated and signals survival | TAS |
| R-HSA-211733 | Regulation of activated PAK-2p34 by proteasome mediated degradation | IEA |
| R-HSA-2122947 | NOTCH1 Intracellular Domain Regulates Transcription | IEA |
| R-HSA-2122948 | Activated NOTCH1 Transmits Signal to the Nucleus | IEA |
| R-HSA-2122948 | Activated NOTCH1 Transmits Signal to the Nucleus | TAS |
| R-HSA-212436 | Generic Transcription Pathway | TAS |
| R-HSA-212436 | Generic Transcription Pathway | IEA |
| R-HSA-2173788 | Downregulation of TGF-beta receptor signaling | IEA |
| R-HSA-2173788 | Downregulation of TGF-beta receptor signaling | TAS |
| R-HSA-2173789 | TGF-beta receptor signaling activates SMADs | IEA |
| R-HSA-2173789 | TGF-beta receptor signaling activates SMADs | TAS |
| R-HSA-2173791 | TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | TAS |
| R-HSA-2173793 | Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | TAS |
| R-HSA-2173793 | Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | IEA |
| R-HSA-2173795 | Downregulation of SMAD2/3:SMAD4 transcriptional activity | TAS |
| R-HSA-2173795 | Downregulation of SMAD2/3:SMAD4 transcriptional activity | IEA |
| R-HSA-2173796 | SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | IEA |
| R-HSA-2173796 | SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | TAS |
| R-HSA-2262749 | Cellular response to hypoxia | TAS |
| R-HSA-2262752 | Cellular responses to stress | TAS |
| R-HSA-2408522 | Selenoamino acid metabolism | IEA |
| R-HSA-2408557 | Selenocysteine synthesis | IEA |
| R-HSA-2454202 | Fc epsilon receptor (FCERI) signaling | TAS |
| R-HSA-2467813 | Separation of Sister Chromatids | TAS |
| R-HSA-2555396 | Mitotic Metaphase and Anaphase | TAS |
| R-HSA-2559580 | Oxidative Stress Induced Senescence | TAS |
| R-HSA-2559582 | Senescence-Associated Secretory Phenotype (SASP) | TAS |
| R-HSA-2559583 | Cellular Senescence | TAS |
| R-HSA-2559585 | Oncogene Induced Senescence | TAS |
| R-HSA-2565942 | Regulation of PLK1 Activity at G2/M Transition | TAS |
| R-HSA-2644602 | Signaling by NOTCH1 PEST Domain Mutants in Cancer | TAS |
| R-HSA-2644603 | Signaling by NOTCH1 in Cancer | TAS |
| R-HSA-2644606 | Constitutive Signaling by NOTCH1 PEST Domain Mutants | TAS |
| R-HSA-2672351 | Stimuli-sensing channels | TAS |
| R-HSA-2691230 | Signaling by NOTCH1 HD Domain Mutants in Cancer | TAS |
| R-HSA-2691232 | Constitutive Signaling by NOTCH1 HD Domain Mutants | TAS |
| R-HSA-2871837 | FCERI mediated NF-kB activation | TAS |
| R-HSA-2894858 | Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | TAS |
| R-HSA-2894862 | Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | TAS |
| R-HSA-2979096 | NOTCH2 Activation and Transmission of Signal to the Nucleus | IEA |
| R-HSA-3134975 | Regulation of innate immune responses to cytosolic DNA | TAS |
| R-HSA-3229121 | Glycogen storage diseases | TAS |
| R-HSA-3322077 | Glycogen synthesis | TAS |
| R-HSA-349425 | Autodegradation of the E3 ubiquitin ligase COP1 | TAS |
| R-HSA-3700989 | Transcriptional Regulation by TP53 | TAS |
| R-HSA-376176 | Signaling by ROBO receptors | TAS |
| R-HSA-376176 | Signaling by ROBO receptors | IEA |
| R-HSA-3769402 | Deactivation of the beta-catenin transactivating complex | TAS |
| R-HSA-3785653 | Myoclonic epilepsy of Lafora | TAS |
| R-HSA-382551 | Transport of small molecules | TAS |
| R-HSA-382556 | ABC-family proteins mediated transport | TAS |
| R-HSA-3858494 | Beta-catenin independent WNT signaling | TAS |
| R-HSA-392499 | Metabolism of proteins | TAS |
| R-HSA-392499 | Metabolism of proteins | IEA |
| R-HSA-400253 | Circadian Clock | IEA |
| R-HSA-4086400 | PCP/CE pathway | TAS |
| R-HSA-422475 | Axon guidance | TAS |
| R-HSA-422475 | Axon guidance | IEA |
| R-HSA-445989 | TAK1 activates NFkB by phosphorylation and activation of IKKs complex | TAS |
| R-HSA-446203 | Asparagine N-linked glycosylation | TAS |
| R-HSA-446652 | Interleukin-1 family signaling | TAS |
| R-HSA-448424 | Interleukin-17 signaling | TAS |
| R-HSA-449147 | Signaling by Interleukins | TAS |
| R-HSA-450294 | MAP kinase activation | TAS |
| R-HSA-450302 | activated TAK1 mediates p38 MAPK activation | TAS |
| R-HSA-450321 | JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | TAS |
| R-HSA-450408 | AUF1 (hnRNP D0) binds and destabilizes mRNA | TAS |
| R-HSA-450531 | Regulation of mRNA stability by proteins that bind AU-rich elements | TAS |
| R-HSA-453274 | Mitotic G2-G2/M phases | TAS |
| R-HSA-453276 | Regulation of mitotic cell cycle | TAS |
| R-HSA-453279 | Mitotic G1-G1/S phases | TAS |
| R-HSA-4608870 | Asymmetric localization of PCP proteins | TAS |
| R-HSA-4641257 | Degradation of AXIN | TAS |
| R-HSA-4641258 | Degradation of DVL | TAS |
| R-HSA-4641263 | Regulation of FZD by ubiquitination | TAS |
| R-HSA-512988 | Interleukin-3, 5 and GM-CSF signaling | TAS |
| R-HSA-5205647 | Mitophagy | TAS |
| R-HSA-5205685 | Pink/Parkin Mediated Mitophagy | TAS |
| R-HSA-5213460 | RIPK1-mediated regulated necrosis | TAS |
| R-HSA-5218859 | Regulated Necrosis | TAS |
| R-HSA-532668 | N-glycan trimming in the ER and Calnexin/Calreticulin cycle | TAS |
| R-HSA-5357801 | Programmed Cell Death | IEA |
| R-HSA-5357801 | Programmed Cell Death | TAS |
| R-HSA-5357905 | Regulation of TNFR1 signaling | TAS |
| R-HSA-5357956 | TNFR1-induced NFkappaB signaling pathway | TAS |
| R-HSA-5358346 | Hedgehog ligand biogenesis | TAS |
| R-HSA-5358351 | Signaling by Hedgehog | TAS |
| R-HSA-5358351 | Signaling by Hedgehog | IEA |
| R-HSA-5362768 | Hh mutants that don't undergo autocatalytic processing are degraded by ERAD | TAS |
| R-HSA-5387390 | Hh mutants abrogate ligand secretion | TAS |
| R-HSA-5607761 | Dectin-1 mediated noncanonical NF-kB signaling | TAS |
| R-HSA-5607764 | CLEC7A (Dectin-1) signaling | TAS |
| R-HSA-5610780 | Degradation of GLI1 by the proteasome | TAS |
| R-HSA-5610783 | Degradation of GLI2 by the proteasome | IEA |
| R-HSA-5610785 | GLI3 is processed to GLI3R by the proteasome | TAS |
| R-HSA-5610787 | Hedgehog 'off' state | TAS |
| R-HSA-5610787 | Hedgehog 'off' state | IEA |
| R-HSA-5619084 | ABC transporter disorders | TAS |
| R-HSA-5619115 | Disorders of transmembrane transporters | TAS |
| R-HSA-5621481 | C-type lectin receptors (CLRs) | TAS |
| R-HSA-5632684 | Hedgehog 'on' state | TAS |
| R-HSA-5632684 | Hedgehog 'on' state | IEA |
| R-HSA-5633007 | Regulation of TP53 Activity | TAS |
| R-HSA-5637815 | Signaling by Ligand-Responsive EGFR Variants in Cancer | TAS |
| R-HSA-5653656 | Vesicle-mediated transport | TAS |
| R-HSA-5654726 | Negative regulation of FGFR1 signaling | TAS |
| R-HSA-5654727 | Negative regulation of FGFR2 signaling | TAS |
| R-HSA-5654732 | Negative regulation of FGFR3 signaling | TAS |
| R-HSA-5654733 | Negative regulation of FGFR4 signaling | TAS |
| R-HSA-5654736 | Signaling by FGFR1 | TAS |
| R-HSA-5654738 | Signaling by FGFR2 | TAS |
| R-HSA-5654741 | Signaling by FGFR3 | TAS |
| R-HSA-5654743 | Signaling by FGFR4 | TAS |
| R-HSA-5655862 | Translesion synthesis by POLK | TAS |
| R-HSA-5656121 | Translesion synthesis by POLI | TAS |
| R-HSA-5656169 | Termination of translesion DNA synthesis | TAS |
| R-HSA-5658442 | Regulation of RAS by GAPs | TAS |
| R-HSA-5663084 | Diseases of carbohydrate metabolism | TAS |
| R-HSA-5663202 | Diseases of signal transduction | TAS |
| R-HSA-5663205 | Infectious disease | TAS |
| R-HSA-5668541 | TNFR2 non-canonical NF-kB pathway | TAS |
| R-HSA-5668914 | Diseases of metabolism | TAS |
| R-HSA-5673001 | RAF/MAP kinase cascade | TAS |
| R-HSA-5675221 | Negative regulation of MAPK pathway | TAS |
| R-HSA-5675482 | Regulation of necroptotic cell death | TAS |
| R-HSA-5676590 | NIK-->noncanonical NF-kB signaling | TAS |
| R-HSA-5678895 | Defective CFTR causes cystic fibrosis | TAS |
| R-HSA-5683057 | MAPK family signaling cascades | TAS |
| R-HSA-5684264 | MAP3K8 (TPL2)-dependent MAPK1/3 activation | TAS |
| R-HSA-5684996 | MAPK1/MAPK3 signaling | TAS |
| R-HSA-5685942 | HDR through Homologous Recombination (HRR) | TAS |
| R-HSA-5687128 | MAPK6/MAPK4 signaling | TAS |
| R-HSA-5688426 | Deubiquitination | TAS |
| R-HSA-5688426 | Deubiquitination | IEA |
| R-HSA-5689603 | UCH proteinases | TAS |
| R-HSA-5689603 | UCH proteinases | IEA |
| R-HSA-5689877 | Josephin domain DUBs | TAS |
| R-HSA-5689880 | Ub-specific processing proteases | TAS |
| R-HSA-5689896 | Ovarian tumor domain proteases | TAS |
| R-HSA-5689901 | Metalloprotease DUBs | TAS |
| R-HSA-5693532 | DNA Double-Strand Break Repair | TAS |
| R-HSA-5693538 | Homology Directed Repair | TAS |
| R-HSA-5693565 | Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | TAS |
| R-HSA-5693567 | HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA) | TAS |
| R-HSA-5693606 | DNA Double Strand Break Response | TAS |
| R-HSA-5693607 | Processing of DNA double-strand break ends | TAS |
| R-HSA-5696394 | DNA Damage Recognition in GG-NER | TAS |
| R-HSA-5696395 | Formation of Incision Complex in GG-NER | TAS |
| R-HSA-5696397 | Gap-filling DNA repair synthesis and ligation in GG-NER | TAS |
| R-HSA-5696398 | Nucleotide Excision Repair | TAS |
| R-HSA-5696399 | Global Genome Nucleotide Excision Repair (GG-NER) | TAS |
| R-HSA-5696400 | Dual Incision in GG-NER | TAS |
| R-HSA-597592 | Post-translational protein modification | TAS |
| R-HSA-597592 | Post-translational protein modification | IEA |
| R-HSA-6781823 | Formation of TC-NER Pre-Incision Complex | TAS |
| R-HSA-6781827 | Transcription-Coupled Nucleotide Excision Repair (TC-NER) | TAS |
| R-HSA-6782135 | Dual incision in TC-NER | TAS |
| R-HSA-6782210 | Gap-filling DNA repair synthesis and ligation in TC-NER | TAS |
| R-HSA-6783310 | Fanconi Anemia Pathway | TAS |
| R-HSA-6791226 | Major pathway of rRNA processing in the nucleolus and cytosol | TAS |
| R-HSA-6804756 | Regulation of TP53 Activity through Phosphorylation | TAS |
| R-HSA-6804757 | Regulation of TP53 Degradation | TAS |
| R-HSA-6804760 | Regulation of TP53 Activity through Methylation | TAS |
| R-HSA-6806003 | Regulation of TP53 Expression and Degradation | TAS |
| R-HSA-6806834 | Signaling by MET | TAS |
| R-HSA-6807004 | Negative regulation of MET activity | TAS |
| R-HSA-6807070 | PTEN Regulation | TAS |
| R-HSA-68827 | CDT1 association with the CDC6:ORC:origin complex | TAS |
| R-HSA-68867 | Assembly of the pre-replicative complex | TAS |
| R-HSA-68874 | M/G1 Transition | TAS |
| R-HSA-68882 | Mitotic Anaphase | TAS |
| R-HSA-68886 | M Phase | TAS |
| R-HSA-68949 | Orc1 removal from chromatin | TAS |
| R-HSA-69002 | DNA Replication Pre-Initiation | TAS |
| R-HSA-69017 | CDK-mediated phosphorylation and removal of Cdc6 | TAS |
| R-HSA-69052 | Switching of origins to a post-replicative state | TAS |
| R-HSA-69202 | Cyclin E associated events during G1/S transition | TAS |
| R-HSA-69206 | G1/S Transition | TAS |
| R-HSA-69229 | Ubiquitin-dependent degradation of Cyclin D1 | TAS |
| R-HSA-69231 | Cyclin D associated events in G1 | TAS |
| R-HSA-69236 | G1 Phase | TAS |
| R-HSA-69239 | Synthesis of DNA | TAS |
| R-HSA-69242 | S Phase | TAS |
| R-HSA-69275 | G2/M Transition | TAS |
| R-HSA-69278 | Cell Cycle, Mitotic | TAS |
| R-HSA-69306 | DNA Replication | TAS |
| R-HSA-69481 | G2/M Checkpoints | TAS |
| R-HSA-69541 | Stabilization of p53 | TAS |
| R-HSA-69563 | p53-Dependent G1 DNA Damage Response | TAS |
| R-HSA-69580 | p53-Dependent G1/S DNA damage checkpoint | TAS |
| R-HSA-69601 | Ubiquitin Mediated Degradation of Phosphorylated Cdc25A | TAS |
| R-HSA-69610 | p53-Independent DNA Damage Response | TAS |
| R-HSA-69613 | p53-Independent G1/S DNA damage checkpoint | TAS |
| R-HSA-69615 | G1/S DNA Damage Checkpoints | TAS |
| R-HSA-69620 | Cell Cycle Checkpoints | TAS |
| R-HSA-69656 | Cyclin A:Cdk2-associated events at S phase entry | TAS |
| R-HSA-71291 | Metabolism of amino acids and derivatives | IEA |
| R-HSA-71387 | Metabolism of carbohydrates | TAS |
| R-HSA-72312 | rRNA processing | TAS |
| R-HSA-72613 | Eukaryotic Translation Initiation | TAS |
| R-HSA-72689 | Formation of a pool of free 40S subunits | TAS |
| R-HSA-72706 | GTP hydrolysis and joining of the 60S ribosomal subunit | TAS |
| R-HSA-72737 | Cap-dependent Translation Initiation | TAS |
| R-HSA-72764 | Eukaryotic Translation Termination | IEA |
| R-HSA-72766 | Translation | TAS |
| R-HSA-72766 | Translation | IEA |
| R-HSA-73857 | RNA Polymerase II Transcription | TAS |
| R-HSA-73857 | RNA Polymerase II Transcription | IEA |
| R-HSA-73887 | Death Receptor Signalling | TAS |
| R-HSA-73893 | DNA Damage Bypass | TAS |
| R-HSA-73894 | DNA Repair | TAS |
| R-HSA-74160 | Gene expression (Transcription) | TAS |
| R-HSA-74160 | Gene expression (Transcription) | IEA |
| R-HSA-75815 | Ubiquitin-dependent degradation of Cyclin D | TAS |
| R-HSA-75893 | TNF signaling | TAS |
| R-HSA-8848021 | Signaling by PTK6 | TAS |
| R-HSA-8849469 | PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | TAS |
| R-HSA-8852135 | Protein ubiquitination | TAS |
| R-HSA-8852135 | Protein ubiquitination | IEA |
| R-HSA-8852276 | The role of GTSE1 in G2/M progression after G2 checkpoint | TAS |
| R-HSA-8854050 | FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | TAS |
| R-HSA-8856825 | Cargo recognition for clathrin-mediated endocytosis | TAS |
| R-HSA-8856828 | Clathrin-mediated endocytosis | TAS |
| R-HSA-8863795 | Downregulation of ERBB2 signaling | TAS |
| R-HSA-8866652 | Synthesis of active ubiquitin: roles of E1 and E2 enzymes | TAS |
| R-HSA-8866652 | Synthesis of active ubiquitin: roles of E1 and E2 enzymes | IEA |
| R-HSA-8866654 | E3 ubiquitin ligases ubiquitinate target proteins | TAS |
| R-HSA-8868773 | rRNA processing in the nucleus and cytosol | TAS |
| R-HSA-8875360 | InlB-mediated entry of Listeria monocytogenes into host cell | TAS |
| R-HSA-8876384 | Listeria monocytogenes entry into host cells | TAS |
| R-HSA-8876493 | InlA-mediated entry of Listeria monocytogenes into host cells | TAS |
| R-HSA-8878159 | Transcriptional regulation by RUNX3 | TAS |
| R-HSA-8878166 | Transcriptional regulation by RUNX2 | TAS |
| R-HSA-8878166 | Transcriptional regulation by RUNX2 | IEA |
| R-HSA-8878171 | Transcriptional regulation by RUNX1 | TAS |
| R-HSA-8939236 | RUNX1 regulates transcription of genes involved in differentiation of HSCs | TAS |
| R-HSA-8939902 | Regulation of RUNX2 expression and activity | TAS |
| R-HSA-8939902 | Regulation of RUNX2 expression and activity | IEA |
| R-HSA-8941858 | Regulation of RUNX3 expression and activity | TAS |
| R-HSA-8948747 | Regulation of PTEN localization | TAS |
| R-HSA-8948751 | Regulation of PTEN stability and activity | TAS |
| R-HSA-8951664 | Neddylation | TAS |
| R-HSA-8953854 | Metabolism of RNA | TAS |
| R-HSA-8953897 | Cellular responses to external stimuli | TAS |
| R-HSA-8982491 | Glycogen metabolism | TAS |
| R-HSA-9006925 | Intracellular signaling by second messengers | TAS |
| R-HSA-9006927 | Signaling by Non-Receptor Tyrosine Kinases | TAS |
| R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases | TAS |
| R-HSA-9006936 | Signaling by TGF-beta family members | TAS |
| R-HSA-9006936 | Signaling by TGF-beta family members | IEA |
| R-HSA-901032 | ER Quality Control Compartment (ERQC) | TAS |
| R-HSA-901042 | Calnexin/calreticulin cycle | TAS |
| R-HSA-9010553 | Regulation of expression of SLITs and ROBOs | TAS |
| R-HSA-9010553 | Regulation of expression of SLITs and ROBOs | IEA |
| R-HSA-9012852 | Signaling by NOTCH3 | IEA |
| R-HSA-9012852 | Signaling by NOTCH3 | TAS |
| R-HSA-9013507 | NOTCH3 Activation and Transmission of Signal to the Nucleus | IEA |
| R-HSA-9013507 | NOTCH3 Activation and Transmission of Signal to the Nucleus | TAS |
| R-HSA-9013973 | TICAM1-dependent activation of IRF3/IRF7 | TAS |
| R-HSA-9014325 | TICAM1,TRAF6-dependent induction of TAK1 complex | TAS |
| R-HSA-9020702 | Interleukin-1 signaling | TAS |
| R-HSA-9033241 | Peroxisomal protein import | IEA |
| R-HSA-9033241 | Peroxisomal protein import | TAS |
| R-HSA-912631 | Regulation of signaling by CBL | TAS |
| R-HSA-913531 | Interferon Signaling | TAS |
| R-HSA-917729 | Endosomal Sorting Complex Required For Transport (ESCRT) | TAS |
| R-HSA-917937 | Iron uptake and transport | TAS |
| R-HSA-927802 | Nonsense-Mediated Decay (NMD) | TAS |
| R-HSA-936440 | Negative regulators of DDX58/IFIH1 signaling | TAS |
| R-HSA-936964 | Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon | TAS |
| R-HSA-937039 | IRAK1 recruits IKK complex | TAS |
| R-HSA-937041 | IKK complex recruitment mediated by RIP1 | TAS |
| R-HSA-937042 | IRAK2 mediated activation of TAK1 complex | TAS |
| R-HSA-937061 | TRIF(TICAM1)-mediated TLR4 signaling | TAS |
| R-HSA-937072 | TRAF6-mediated induction of TAK1 complex within TLR4 complex | TAS |
| R-HSA-975110 | TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | TAS |
| R-HSA-975138 | TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | TAS |
| R-HSA-975144 | IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | TAS |
| R-HSA-975155 | MyD88 dependent cascade initiated on endosome | TAS |
| R-HSA-975163 | IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | TAS |
| R-HSA-975871 | MyD88 cascade initiated on plasma membrane | TAS |
| R-HSA-975956 | Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | TAS |
| R-HSA-975957 | Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | TAS |
| R-HSA-977225 | Amyloid fiber formation | TAS |
| R-HSA-983168 | Antigen processing: Ubiquitination & Proteasome degradation | TAS |
| R-HSA-983169 | Class I MHC mediated antigen processing & presentation | TAS |
| R-HSA-983169 | Class I MHC mediated antigen processing & presentation | IEA |
| R-HSA-983705 | Signaling by the B Cell Receptor (BCR) | TAS |
| R-HSA-983712 | Ion channel transport | TAS |